Page last updated: 2024-12-07

hexahydrodifenidol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hexahydrodifenidol: muscarinic antagonist; RN from Toxlit [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID124226
MeSH IDM0168511

Synonyms (13)

Synonym
gtpl322
L023948
hexahydrodifenidol
1-cyclohexyl-1-phenyl-4-piperidin-1-ylbutan-1-ol
cas_113010-69-8
bdbm81960
hexahydrodiphenidol
hexahydro-diphenidol
113010-69-8
piperidinebutanol, alpha-cyclohexyl-alpha-phenyl-
1-cyclohexyl-1-phenyl-4-(piperidin-1-yl)butan-1-ol
DTXSID60920977
Q27077979
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1345343Human M3 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345543Human M5 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345326Human M2 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345189Rat M1 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
AID1345465Human M4 receptor (Acetylcholine receptors (muscarinic))1989Molecular pharmacology, Apr, Volume: 35, Issue:4
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (50.00)18.7374
1990's5 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.96

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.96 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.96)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]